UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 241

Sortiert nach

Less Can Be More: The Hormesis Theory of Stress Adaptation in the Global Biosphere and Its Implications

Biomedicines, 2021-03, Vol.9 (3), p.293

Schirrmacher, Volker

2021

Link zum Volltext

Verfügbarkeit prüfen

Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis

Biomedicines, 2020-03, Vol.8 (3), p.61

Schirrmacher, Volker

2020

Link zum Volltext

Verfügbarkeit prüfen

Bone Marrow: The Central Immune System

Immuno, 2023-09, Vol.3 (3), p.289-329

Schirrmacher, Volker

2023

Link zum Volltext

Verfügbarkeit prüfen

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Methods in molecular biology (Clifton, N.J.), 2009, Vol.542, p.565

2009

Link zum Volltext

Verfügbarkeit prüfen

Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution

Biomedicines, 2024-04, Vol.12 (4), p.754

2024

Link zum Volltext

Verfügbarkeit prüfen

Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

Journal of Virology, 2009-08, Vol.83 (16), p.8108-8121

2009

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance

Expert opinion on biological therapy, 2015-12, Vol.15 (12), p.1757-1771

Schirrmacher, Volker

2015

Link zum Volltext

Verfügbarkeit prüfen

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

Expert review of vaccines, 2014-01, Vol.13 (1), p.117-130

2014

Link zum Volltext

Verfügbarkeit prüfen

The Application of Evidence-Based Medicine in Individualized Medicine

Biomedicines, 2023-06, Vol.11 (7), p.1793

2023

Link zum Volltext

Verfügbarkeit prüfen

Cell Surface Expression and Secretion of Heparanase Markedly Promote Tumor Angiogenesis and Metastasis

Proceedings of the National Academy of Sciences - PNAS, 2002-07, Vol.99 (15), p.10031-10036

2002

Link zum Volltext

Verfügbarkeit prüfen

Harnessing oncolytic virus-mediated immunity

2015

Link zum Volltext

Verfügbarkeit prüfen

Complete remission of cancer in late-stage disease by radiation and transfer of allogeneic MHC-matched immune T cells: lessons from GvL studies in animals

Cancer Immunology, Immunotherapy, 2014-06, Vol.63 (6), p.535-543

Schirrmacher, Volker

2014

Link zum Volltext

Verfügbarkeit prüfen

Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer: Preparing for the Future

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2013-02, Vol.27 (1), p.35-53

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Cancer Immunology, Immunotherapy, 2005-06, Vol.54 (6), p.587-598

Schirrmacher, Volker

2005

Link zum Volltext

Verfügbarkeit prüfen

IMMU-25. SYNERGY BETWEEN TMZ AND INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY TO IMPROVE OS OF IDH1 WILD TYPE MGMT PROMOTOR UNMETHYLATED GBM PATIENTS

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi97-vi97

2021

Link zum Volltext

Verfügbarkeit prüfen

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

Genes and immunity, 2022-12, Vol.23 (8), p.255-259

2022

Link zum Volltext

Verfügbarkeit prüfen

IMMU-02. CMV-EXPANDED T-CELLS IN GLIOBLASTOMA PATIENTS: TRANSLATIONAL RESEARCH

Neuro-oncology (Charlottesville, Va.), 2023-06, Vol.25 (Supplement_1), p.i49-i49

2023

Link zum Volltext

Verfügbarkeit prüfen

Influence of Adjuvant Hormone Therapy and Chemotherapy on the Immune System Analysed in the Bone Marrow of Patients with Breast Cancer

Clinical cancer research, 2003-01, Vol.9 (1), p.174-180

2003

Link zum Volltext

Verfügbarkeit prüfen

INNV-18. MULTIPHASE COMBINED TREATMENT, INCLUDING INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY FOR ADULTS WITH GBM: SINGLE INSTITUTE REAL WORLD MEDICAL DATA IN THE LIGHT OF CLINICAL TRIAL RESEARCH DATA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v160-v160

2023

Link zum Volltext

Verfügbarkeit prüfen

QOL-02. MONITORING GBM PATIENT HEALTH-RELATED QUALITY OF LIFE AND QUALITY ADJUSTED LIFE MONTHS DURING INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY USING EQ-5D-5L

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v248-v248

2023

Link zum Volltext

Verfügbarkeit prüfen

IMMU-03. Synergy between TMZ and individualized multimodal immunotherapy to improve Overall Survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i81-i81

2022

Link zum Volltext

Verfügbarkeit prüfen

Randomized clinical studies of anti-tumor vaccination: state of the art in 2008

Expert review of vaccines, 2009-01, Vol.8 (1), p.51-66

2009

Link zum Volltext

Verfügbarkeit prüfen

IMMU-07. IMMUNOGENIC CELL DEATH DURING MAINTENANCE CHEMOTHERAPY AND SUBSEQUENT MULTIMODAL IMMUNOTHERAPY FOR GBM

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i99-i100

2018

Link zum Volltext

Verfügbarkeit prüfen

Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus

Cancer gene therapy, 2005-03, Vol.12 (3), p.295-303

2005

Link zum Volltext

Verfügbarkeit prüfen

PDCT-15. MULTIMODAL IMMUNOTHERAPY AS PART OF MULTIMODAL TREATMENT FOR DIPG

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi187-vi187

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 241

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(218)
Mit Volltextzugriff
(211)

Publikationsform

Sprache

Englisch
(232)
Japanisch
(12)
Deutsch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(138)
Life Sciences & Biomedicine
(131)
Animals
(121)
Mice
(100)
Humans
(79)
Oncology
(78)
Biological And Medical Sciences
(72)
Medical Sciences
(62)
Mice, Inbred Dba
(49)
Female
(46)
Tumors
(44)
Immunology
(42)
T-Lymphocytes - Immunology
(39)
Immunotherapy
(30)
Newcastle Disease Virus
(27)
Cell Line
(25)
Neoplasm Metastasis
(25)
Newcastle Disease Virus - Immunology
(23)
Pharmacology. Drug Treatments
(22)
Tumor Cells, Cultured
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Less Can Be More: The Hormesis Theory of Stress Adaptation in the Global Biosphere and Its Implications

Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis

Bone Marrow: The Central Immune System

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution

Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

The Application of Evidence-Based Medicine in Individualized Medicine

Cell Surface Expression and Secretion of Heparanase Markedly Promote Tumor Angiogenesis and Metastasis

Harnessing oncolytic virus-mediated immunity

Complete remission of cancer in late-stage disease by radiation and transfer of allogeneic MHC-matched immune T cells: lessons from GvL studies in animals

Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer: Preparing for the Future

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

IMMU-25. SYNERGY BETWEEN TMZ AND INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY TO IMPROVE OS OF IDH1 WILD TYPE MGMT PROMOTOR UNMETHYLATED GBM PATIENTS

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

IMMU-02. CMV-EXPANDED T-CELLS IN GLIOBLASTOMA PATIENTS: TRANSLATIONAL RESEARCH

Influence of Adjuvant Hormone Therapy and Chemotherapy on the Immune System Analysed in the Bone Marrow of Patients with Breast Cancer

INNV-18. MULTIPHASE COMBINED TREATMENT, INCLUDING INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY FOR ADULTS WITH GBM: SINGLE INSTITUTE REAL WORLD MEDICAL DATA IN THE LIGHT OF CLINICAL TRIAL RESEARCH DATA

QOL-02. MONITORING GBM PATIENT HEALTH-RELATED QUALITY OF LIFE AND QUALITY ADJUSTED LIFE MONTHS DURING INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY USING EQ-5D-5L

IMMU-03. Synergy between TMZ and individualized multimodal immunotherapy to improve Overall Survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

Randomized clinical studies of anti-tumor vaccination: state of the art in 2008

IMMU-07. IMMUNOGENIC CELL DEATH DURING MAINTENANCE CHEMOTHERAPY AND SUBSEQUENT MULTIMODAL IMMUNOTHERAPY FOR GBM

Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus

PDCT-15. MULTIMODAL IMMUNOTHERAPY AS PART OF MULTIMODAL TREATMENT FOR DIPG

Aktive Filter

Suchergebnisse filtern